SGK
IMNN icon

Steigerwald Gordon & Koch’s Imunon IMNN Stock Holding History

Steigerwald Gordon & Koch’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Hold
1
– – ﹤0.01% 777
2025
Q4 		$4 Hold
1
– – ﹤0.01% 913
2025
Q3 		$5 Buy
+1
New +$7 ﹤0.01% 812

Other funds holding IMNN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Steigerwald Gordon & Koch's IMNN Position: Q1 2026 in Review

Steigerwald Gordon & Koch held its Imunon (IMNN) position steady in Q1 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Steigerwald Gordon & Koch first reported a position in IMNN in Q3 2025 and has held it in 3 quarters since. The position peaked at $5 in Q3 2025. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

  • Steigerwald Gordon & Koch held 1 share of Imunon worth $3 as of Q1 2026.
  • Steigerwald Gordon & Koch left its Imunon share count unchanged in Q1 2026.
  • Imunon made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q1 2026, its #777 holding.
  • Steigerwald Gordon & Koch first reported a position in Imunon in Q3 2025 and has held it in 3 quarters since.
  • Steigerwald Gordon & Koch's Imunon position peaked at $5 in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.